Michael Maeng

Showing 1-19 of 19 articles

Author Manan Pareek

Coronary interventions

Ten-year outcomes from a randomised comparison of zotarolimus-eluting and sirolimus-eluting stents: the SORT OUT III study

Pareek M, Madsen M, Warnakula Olesen K, Okkels Jensen L, Høj Christiansen E, Dalby Kristensen S, Flensted Lassen J, Thuesen L, Bøtker H, Maeng M

December 6, 2019 | 10.4244/EIJ-D-19-00503

Author Alexander Goedel

Coronary interventions

Enhanced platelet inhibition by clopidogrel and risk of bleeding in patients requiring oral anticoagulation after drug-eluting stent implantation

Goedel A, Fiedler K, Mehilli J, Bernlochner I, von Olshausen G, Mayer K, Schüpke S, Hoppmann P, Sibbing D, Maeng M, Massberg S, Schunkert H, Laugwitz K, Kastrati A, Sarafoff N

October 18, 2019 | 10.4244/EIJ-D-18-00995

Author Stefan Verheye

Coronary interventions

Five-year safety and performance data of a novel third-generation novolimus-eluting bioresorbable scaffold in single de novo lesions

Verheye S, Costa R, Schofer J, Ormiston J, Maeng M, Dudek D, Skurk C, Botelho R, Costa J, Chamié D, Abizaid An, Boersma E, Abizaid A

October 18, 2019 | 10.4244/EIJ-D-18-00292

Author Manan Pareek

Coronary interventions

10-year outcomes from a randomized comparison of zotarolimus-eluting and sirolimus-eluting stents: the SORT OUT III study

Pareek M, Madsen M, Warnakula Olesen K, Okkels Jensen L, Høj Christiansen E, Dalby Kristensen S, Flensted Lassen J, Thuesen L, Bøtker H, Maeng M

August 20, 2019 | 10.4244/EIJ-D-19-00503

Author Salvatore Cassese

Coronary interventions

Angiographic and clinical outcomes of STEMI patients treated with bioresorbable or metallic everolimus-eluting stents. A pooled analysis of individual patient data from 2 randomized trials

Cassese S, Katagiri Y, Byrne R, Brugaletta S, Alfonso F, Räber L, Maeng M, Iniguez A, Kretov E, Onuma Y, Joner M, Sabaté M, Laugwitz K, Windecker S, Kastrati A, Serruys P

February 5, 2019 | 10.4244/EIJ-D-18-01080

Author Kirstine Norregaard Hansen

STEMI

One-year rehospitalisation after percutaneous coronary intervention: a retrospective analysis

Hansen KN, Bendix K, Antonsen L, Veien K, Maeng M, Junker A, Christiansen EH, Kahlert J, Terkelsen C, Christensen LB, Fallesen C, Bøtker H, Okkels Jensen L

October 19, 2018 | 10.4244/EIJ-D-17-00800

Author Lisette Okkels Jensen

Two-year outcome after biodegradable polymer sirolimus- and biolimus-eluting coronary stents (from the randomised SORT OUT VII trial)

Okkels Jensen L, Maeng M, Raungaard B, Hansen K, Kahlert J, Jensen S, Hansen H, Flensted Lassen J, Bøtker H, Christiansen E

January 19, 2018 | 10.4244/EIJ-D-17-00731

Author Lars Jakobsen

Final five-year outcomes after implantation of biodegradable polymer-coated biolimus-eluting stents versus durable polymer-coated sirolimus-eluting stents

Jakobsen L, Christiansen E, Maeng M, Hansen K, Kristensen SD, Bøtker H, Terkelsen C, Jensen S, Raungaard B, Madsen M, Flensted Lassen J, Okkels Jensen L

December 20, 2017 | 10.4244/EIJ-D-17-00434

Author Fabio Mangiacapra

Coronary interventions

EXCEL and NOBLE: stents or surgery for left main stem stenosis?

Mangiacapra F, Maeng M, Cayla G, Lansky A, Meier P, Kolh P

August 4, 2017 | 10.4244/EIJV13I5A94

Author Ivy S. Modrau

Feasibility and early safety of hybrid coronary revascularisation combining off-pump coronary surgery through J-hemisternotomy with percutaneous coronary intervention

Modrau I, Nielsen P, Bøtker H, Christiansen E, Krusell L, Kaltoft A, Terkelsen C, Kristensen SD, Flensted Lassen J, Thuesen L, Maeng M

February 20, 2015 | 10.4244/EIJV10I10A195

Author Niels Ramsing Holm

Randomised comparison of manual compression and FemoSeal™ vascular closure device for closure after femoral artery access coronary angiography: the CLOSure dEvices Used in everyday Practice (CLOSE-UP) study

Holm N.R., Sindberg B, Schou M, Maeng M, Kaltoft A, Bottcher M, Krusell L, Hjort J, Thuesen L, Terkelsen C, Christiansen E, Bøtker H, Kristensen SD, Flensted Lassen J

June 20, 2014 | 10.4244/EIJV10I2A31

Author Lisbeth Antonsen

Outcomes after revascularisation with everolimus- and sirolimus-eluting stents in patients with acute coronary syndromes and stable angina pectoris: a substudy of the SORT OUT IV trial

Antonsen L, Thayssen P, Hansen H, Maeng M, Tilsted H, Bøtker H, Ravkilde J, Madsen M, Sørensen H, Thuesen L, Flensted Lassen J, Okkels Jensen L

June 20, 2014 | 10.4244/EIJV10I2A35

Author Per Thayssen

The risk and prognostic impact of definite stent thrombosis or in-stent restenosis after coronary stent implantation

Thayssen P, Okkels Jensen L, Flensted Lassen J, Tilsted H, Kaltoft A, Christiansen E, Hansen K, Ravkilde J, Maeng M, Krusell L, Madsen M, Sørensen H, Thuesen L

September 28, 2012 | 10.4244/EIJV8I5A91

Author Lisette Okkels Jensen

Culprit only or multivessel percutaneous coronary interventions in patients with ST-segment elevation myocardial infarction and multivessel disease

Okkels Jensen L, Thayssen P, Farkas D, Hougaard M, Terkelsen C, Tilsted H, Maeng M, Junker A, Flensted Lassen J, Horv E, Sørensen H, Thuesen L

August 24, 2012 | 10.4244/EIJV8I4A72

Author Indulis Kumsars

Side branch fractional flow reserve measurements after main vessel stenting: a Nordic-Baltic Bifurcation Study III substudy

Kumsars I, Narbute I, Thuesen L, Niemelä M, Steigen T, Kervinen K, Sondore D, Holm N.R., Flensted Lassen J, Christiansen E, Maeng M, Jegere S, Juhnevica D, Erglis A

February 21, 2012 | 10.4244/EIJV7I10A186

Author Niels Ramsing Holm

Use of three-dimensional optical coherence tomography to verify correct wire position in a jailed side branch after main vessel stent implantation

Holm N.R., Tu S, Christiansen E, Reiber J, Flensted Lassen J, Thuesen L, Maeng M

August 30, 2011 | 10.4244/EIJV7I4A84

Author Lisette Okkels Jensen

Late lumen loss and intima hyperplasia after sirolimus-eluting and zotarolimus-eluting stent implantation in diabetic patients: the diabetes and drug-eluting stent (DiabeDES III) angiography and intravascular ultrasound trial

Okkels Jensen L, Maeng M, Thayssen P, Villadsen A, Krusell L, Bøtker H, Pedersen K, Aaroe J, Christiansen E, Vesterlund T, Hansen K, Ravkilde J, Tilsted H, Flensted Lassen J, Thuesen L

July 29, 2011 | 10.4244/EIJV7I3A56

Author Lisette Okkels Jensen

Paclitaxel and sirolimus eluting stents versus bare metal stents: long-term risk of stent thrombosis and other outcomes

Okkels Jensen L, Tilsted H, Thayssen P, Kaltoft A, Maeng M, Flensted Lassen J, Noerregaard Hansen K, Madsen M, Ravkilde J, Johnsen S, Sørensen H, Thuesen L

April 12, 2010

Author L Okkels Jensen

Impact of drug eluting stents on target vessel revascularization. A report from the Western Denmark heart registry from 2000 to 2004.

Okkels Jensen L, Maeng M, Thayssen P, Flensted Lassen J, Bøtker H, Rasmussen K, Thuesen L

February 20, 2006

1

Latest news

Antiplatelet strategies for complex PCI, are all DES equal at 10-year follow-up? cost-effectiveness of TAVR…find all the answers in the new issue

(Intravascular lithotripsy (3.5 mm Shockwave; left), followed by balloon dilatation (4.0 mm NC; right))

December 6, 2019

Discover 5 new trials: GALILEO, CONDI-2/ERIC-PCI, EVOLUTE II-5 years, SCOPE and Excel 5 years

(The Trials book is supported by Biotronik)

December 13, 2019

New this week: A Dose-response Meta Analysis, stroke after MitraClip and more

December 10, 2019

The challenge of innovation for the (interventional?) cardiology world

December 6, 2019

Guidance Papers

Guidelines, consensus & position papers

2019 – A leap year for valvular heart disease

(Course directors PCR London Valves 2019)

November 15, 2019

Last week's JAA's: EXTREME Study, Stent Optimization and more

December 3, 2019

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke